The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation by Fumiaki Banno, Anil K. Chauhan, Koichi Kokame,

Slides:



Advertisements
Similar presentations
Red blood cells mediate the onset of thrombosis in the ferric chloride murine model by Justin D. Barr, Anil K. Chauhan, Gilbert V. Schaeffer, Jessica K.
Advertisements

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice by Sravya Kattula, James R. Byrnes,
by Mark T. Boyd, Brian Foley, and Isadore Brodsky
by Sergei Merkulov, Wan-Ming Zhang, Anton A. Komar, Alvin H
Reduced thrombus stability in mice lacking the α2A-adrenergic receptor
by Matt W. Goschnick, Lai-Man Lau, Janet L. Wee, Yong S. Liu, P
Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease by Alec A. Schmaier,
Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the.
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 by Koichi Kokame, Masanori Matsumoto, Yoshihiro.
Platelet-associated PF-4 as a biomarker of early tumor growth
by Jian-Min Wang, Hong Zheng, Mila Blaivas, and Kotoku Kurachi
Alternative Splicing of a Novel Glycophorin Allele GPHe(GL) Generates Two Protein Isoforms in the Human Erythrocyte Membrane by Cheng-Han Huang, Olga O.
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,
Vessel wall BAMBI contributes to hemostasis and thrombus stability
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura by Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich.
Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins  Li Li, Charles N. Falany 
Volume 117, Issue 3, Pages (September 1999)
by Martha B. Johnson, and Caroline A. Enns
by Weiqiang Gao, Patricia J. Anderson, and J. Evan Sadler
Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9 by Miguel Angel de la Fuente, Victoria.
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA by Rosanna Asselta, Valeria Rimoldi, Ilaria.
by Jing Huang, David G. Motto, David R. Bundle, and J. Evan Sadler
In Vivo Expression of Murine Platelet Glycoprotein Ibα
The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6−/− mice by Yann Cheli, Deborah Jensen, Patrizia Marchese, David.
Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)‏ by Barbara Plaimauer, Klaus Zimmermann,
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1 by Natasja K. van den Engel, Edmund Heidenthal, Antje Vinke,
Impaired activation of platelets lacking protein kinase C-θ isoform
The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis by Hongmin Sun, Tony L. Yang, Angela.
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
A Point Mutation Thr799Met on the 2 Integrin Leads to the Formation of New Human Platelet Alloantigen Sita and Affects Collagen-Induced Aggregation by.
Volume 102, Issue 6, Pages (September 2000)
Volume 117, Issue 3, Pages (September 1999)
FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection by Timothy J. Wilson, Rachel M. Presti,
Volume 20, Issue 2, Pages (February 2012)
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008
Rapid ubiquitination of Syk following GPVI activation in platelets
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.
by Kwang-Hyun Baek, Michelle A
by Yuko Kimura, Takashi Miwa, Lin Zhou, and Wen-Chao Song
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo  Markus Wagner, Martha E. Lopez, Mitch.
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations by Bénédicte Dumont, Dominique Lasne, Chantal Rothschild,
Localization of the ammonium transporters, Rh B glycoprotein and Rh C glycoprotein, in the mouse liver  I.David Weiner, R.Tyler Miller, Jill W Verlander 
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 16, Issue 2, Pages (February 2008)
Epidermal Overexpression of Stratum Corneum Chymotryptic Enzyme in Mice: A Model for Chronic Itchy Dermatitis  Assar Bäckman, Annelii Ny, Michael Edlund,
Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis by Manasa K. Nayak, Nirav Dhanesha,
A Novel Mouse Gene, Sh3yl1, is Expressed in the Anagen Hair Follicle
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.
Northern blot and Western blot analysis of syndecan-4 expression in TF-1 and HEL cells. Northern blot and Western blot analysis of syndecan-4 expression.
by Changjie Zhang, Anju Kelkar, and Sriram Neelamegham
The molecular biology of thrombotic microangiopathy
A Mutation in the Variable Repeat Region of the Aggrecan Gene (AGC1) Causes a Form of Spondyloepiphyseal Dysplasia Associated with Severe, Premature.
Volume 20, Issue 2, Pages (February 2012)
ELMO1 deficiency enhances platelet function
Impact of RTEL1 variants on telomere maintenance.
by Sreenivasulu Chintala, Jian Tan, Rashi Gautam, Michael E
Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers by Debargh Dutta, Devi Gunasekera,
Volume 64, Issue 3, Pages (September 2003)
The molecular biology of thrombotic microangiopathy
Volume 18, Issue 6, Pages (June 2010)
by Alyssa J. Moroi, Nicole M. Zwifelhofer, Matthew J. Riese, Debra K
Volume 25, Issue 4, Pages (April 2017)
Long-Term and Therapeutic-Level Hepatic Gene Expression of Human Factor IX after Naked Plasmid Transfer in Vivo  Carol H. Miao, Arthur R. Thompson, Keith.
Mutation of the Ca2+ Channel β Subunit Gene Cchb4 Is Associated with Ataxia and Seizures in the Lethargic (lh) Mouse  Daniel L Burgess, Julie M Jones,
Endogenously produced n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in vivo. Endogenously produced n-3 PUFAs inhibit endometrial cancer.
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter  Lawrence E Ostrowski, James R Hutchins,
Presentation transcript:

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation by Fumiaki Banno, Anil K. Chauhan, Koichi Kokame, Jin Yang, Shigeki Miyata, Denisa D. Wagner, and Toshiyuki Miyata Blood Volume 113(21):5323-5329 May 21, 2009 ©2009 by American Society of Hematology

Generation of Adamts13S/S mice with 129/Sv-genetic background. Generation of Adamts13S/S mice with 129/Sv-genetic background. (A) Gene and protein structure of ADAMTS13 in the wild-type (Adamts13L/L) 129/Sv mice, the Adamts13S/S mice on 129/Sv genetic background, and the Adamts13−/− mice on 129/Sv genetic background. An intracisternal A-particle (IAP) insertion into intron 23 creates a pseudo-exon 24 including a premature stop codon. ADAMTS13 with a truncated C-terminus is expressed mainly in Adamts13S/S mice. S indicates signal peptide; P, propeptide; MP, metalloprotease domain; Dis, disintegrin-like domain; T (numbered 1-8), thrombospondin type 1 motif domain; Cys, cysteine-rich domain; Sp, spacer domain; and CUB, complement components C1r/C1s, urchin epidermal growth factor, and bone morphogenic protein-1 domain. (B) Expression of Adamts13 mRNA in liver. Poly(A)+ RNA isolated from liver of indicated mice was probed with a 1.3-kb Adamts13 cDNA corresponding to exons 3 to 13. (C) GST-mVWF73-H assay. Plasma ADAMTS13 activity of indicated mice was measured using a recombinant mouse VWF73 peptide, GST-mVWF73-H. Results from 6 mice for each genotype are shown. Standard reactions using graded amounts of pooled plasma from 10 Adamts13L/L mice were performed simultaneously. (D) FRETS-VWF73 assay. Plasma ADAMTS13 activity in indicated mice was determined using a fluorogenic human VWF73 peptide, FRETS-VWF73. Data are mean ± SD of 6 mice for each genotype. The average activity measured in Adamts13L/L mice was arbitrarily defined as 100%. Fumiaki Banno et al. Blood 2009;113:5323-5329 ©2009 by American Society of Hematology

Plasma VWF multimers. Plasma VWF multimers. (A) VWF multimer patterns. Plasma samples (1 μL/lane) from Adamts13L/L, Adamts13S/S, and Adamts13−/− mice were electrophoresed on SDS-agarose gels and transferred to nitrocellulose membranes. VWF multimers were detected with anti-VWF antibodies. (B) Relative intensities of plasma VWF multimers. The chemiluminescent intensities of the VWF multimer patterns (A) were scanned using image analysis software. An average of multiple lanes from 4 mice for each genotype is shown. HMW indicates high molecular weight; LMW, low molecular weight. Fumiaki Banno et al. Blood 2009;113:5323-5329 ©2009 by American Society of Hematology

In vitro thrombogenesis on collagen surface under flow. In vitro thrombogenesis on collagen surface under flow. (A) Thrombus formation at 1000 s−1. Whole blood from Adamts13L/L, Adamts13S/S, or Adamts13−/− mice containing mepacrine-labeled platelets was perfused over an acid-insoluble type I collagen–coated surface at a wall shear rate of 1000 s−1. The cumulative thrombus volume, analyzed using a multidimensional imaging system, was measured every 0.5 minutes until 4 minutes. Data are the mean ± SEM of 25 mice for each genotype. (B) Thrombus formation at 5000 s−1. Whole-blood samples from indicated mice were perfused over an acid-insoluble type I collagen–coated surface at a wall shear rate of 5000 s−1. The cumulative thrombus volume was measured every 20 seconds until 80 seconds. Blood from 2 mice was pooled and used for experiments. Data are the mean ± SEM of 15 samples for each genotype. *P < .05 in comparison with Adamts13L/L mice. Fumiaki Banno et al. Blood 2009;113:5323-5329 ©2009 by American Society of Hematology

In vivo thrombogenesis in ferric chloride–injured mesenteric arterioles. In vivo thrombogenesis in ferric chloride–injured mesenteric arterioles. (A) Time to first thrombus formation. Calcein AM–labeled platelets representing approximately 2.5% of total platelets were observed in mesenteric arterioles of live mice after injury with 10% ferric chloride. The time required for formation of a thrombus more than 30 μm was measured. (B) Occlusion time. The time required for a complete stop of blood flow was measured after injury with 10% ferric chloride. Symbols represent data from a single mouse. Bars represent the mean values of groups (n = 16 for Adamts13L/L mice, n = 16 for Adamts13S/S mice, and n = 12 for Adamts13−/− mice). Fumiaki Banno et al. Blood 2009;113:5323-5329 ©2009 by American Society of Hematology

Platelet counts after collagen plus epinephrine infusion. Platelet counts after collagen plus epinephrine infusion. Mice were injected with 600 ng/g collagen plus 60 ng/g epinephrine via tail vein and platelet counts were measured 5 minutes after injection. Symbols represent platelet counts from a single mouse. Bars represent the mean values of 25 mice in each group. Platelet counts of untreated mice were not different among the groups. Fumiaki Banno et al. Blood 2009;113:5323-5329 ©2009 by American Society of Hematology